Paroxysmal supraventricular tachycardia in the general population

Journal of the American College of Cardiology

Volumn 31, Issue 1, 1998, Pages 150-157

  Orejarena, Leonardo A ^a   Vidaillet Jr , Humberto ^a   Destefano, Frank ^a   Nordstrom, David L ^a   Vierkant, Robert A ^a   Smith, Peter N ^a   Hayes, John J ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HEART RATE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; PREVALENCE; TACHYCARDIA, PAROXYSMAL; TACHYCARDIA, SUPRAVENTRICULAR; WISCONSIN;

EID: 0031931195     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00422-1     Document Type: Article

References (52)

1. Josephson M, Buxton A, Marchlinski F. The tachyarrhythmias. Isselbacher K, Braunwald E, Wilson JD, et al. Harrison's Principles of Internal Medicine. 13th ed. 1994;1024-1029 McGraw-Hill, New York.
2. Zipes D. Specific arrhythmias diagnosis and treatment . Braunwald E. Heart Disease A Textbook of Cardiovascular Medicine . 4th ed. 1992;688-693 Saunders, Philadelphia.
3. Myerburg R, Kessler K, Castellanos A. Recognition, clinical assessment, and management of arrhythmias and conduction disturbances. Hurst JW. The Heart, Arteries and Veins. 8th ed. 1994;714-717 McGraw-Hill, New York.
4. Akhtar M, Tchou P, Jazayeri M. Mechanisms of clinical tachycardias. Am J Cardiol. 61:(Suppl A):1988;9A-19A.
5. Wellens H, Brugada P. Mechanisms of supraventricular tachycardias. Am J Cardiol. 62:1988;10-15.
6. Akhtar M, Jazayeri M, Sra J, Blanck Z, Deshpande S, Dhala A. Atrioventricular node reentry clinical, electrophysiological and therapeutic considerations . Circulation. 88:1993;282-295.
7. Prystowsky E, Klein G. Cardiac Arrhythmias An Integrated Approach for the Clinician . 1994;237-244 McGraw-Hill, New York.
8. Ganz L, Friedman P. Supraventricular tachycardia. N Engl J Med. 332:1995;162-171.
9. Calkins H, Sousa J, El-Atassi R, et al. Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test. N Engl J Med. 324:1991;1612-1618.
10. Manolis A, Wang P, Estes N III. Radiofrequency catheter ablation for cardiac tachyarrhythmias. Ann Intern Med. 121:1994;452-461.
11. Zipes D. Arrhythmias on the endangerment list [editorial]. J Am Coll Cardiol. 21:1993;918-919.
12. Kay G, Epstein A, Dailey S, Plumb V. Role of radiofrequency ablation in the management of supraventricular arrhythmias experience in 760 consecutive patients . J Cardiovasc Electrophysiol. 4:1993;371-389.
13. Barrington W, Greenfield R, Bacon M, Page R, Wharton M. Treatment of supraventricular tachycardias with transcatheter delivery of radiofrequency current. Am J Med. 93:1992;549-557.
14. de Buitleir M, Sousa J, Bolling S, et al. Reduction in medical care cost associated with radiofrequency catheter ablation of accessory pathways. Am J Cardiol. 68:1991;1656-1661.
15. Kalbfleisch S, Calkins H, Langberg J, et al. Comparison of the cost of radiofrequency catheter modification of the AV node and medical therapy for drug refractory AV node reentrant tachycardia. J Am Coll Cardiol. 19:1992;1583-1587.
16. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Clinical Cardiac Electrophysiologic and Catheter Ablation Procedures). Circulation 1995;92:673-91.
17. Prystowsky E. Tachyarrhythmias the role of antiarrhythmic drugs in the therapeutic hierarchy . Josephson E, Wellens H. Tachycardias Mechanism and Management . 1993;375-381 Futura, Mt. Kisco (NY).
18. Salive M. Referral bias in tertiary care the utility of clinical epidemiology [editorial] . Mayo Clin Proc. 69:1994;808-809.
19. Melton J III. History of the Rochester epidemiologic project. Mayo Clin Proc. 71:1996;266-274.
20. Fletcher R, Fletcher S, Wagner E. Clinical Epidemiology The Essentials . 3rd ed. 1996;2-18 Williams & Wilkins, Baltimore.
21. DeStefano F, Eaker E, Broste S, et al. Epidemiologic research in an integrated medical care system the Marshfield Epidemiologic Study Area . J Clin Epidemiol. 49:1996;643-652.
22. Pritchett E, Smith M, McCarthy E, Lee K. The spontaneous occurrence of paroxysmal supraventricular tachycardia. Circulation. 70:1984;1-16.
23. Kalbfleisch S, El-Atassi R, Calkins H, Langberg J, Morady F. Differentiation of paroxysmal narrow QRS complex tachycardias using the 12-lead electrocardiogram. J Am Coll Cardiol. 21:1993;8-9.
24. Bar F, Brugada P, Dassen W, Wellens H. Differential diagnosis of tachycardia with narrow QRS complex (shorter than 0.12 second). Am J Cardiol. 54:1984;555-560.
25. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
26. Manfreda J, Cuddy E, Tate R, Krahn A, Mathewson F. Regular narrow QRS complex tachycardias in the Manitoba follow-up study (1948-88). Can J Cardiol. 8:1992;195-199.
27. Lindsay B, Chung M, Gamache C, et al. Therapeutic end points for the treatment of atrioventricular node reentrant tachycardia by catheter-guided radiofrequency. J Am Coll Cardiol. 22:1993;733-740.
28. Jackman W, Beckman K, McClelland J, et al. Treatment of supraventricular tachycardia due to atrioventricular nodal reentry by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med. 327:1992;313-318.
29. Chen S, Chiang C, Yang C, et al. Accessory pathway and atrioventricular node reentrant tachycardia in elderly patients clinical features, electrophysiologic characteristics and results of radiofrequency ablation . J Am Coll Cardiol. 23:1994;702-708.
30. Rodriguez L, de Chillou C, Schlapfer J, et al. Age at onset and gender of patients with different types of supraventricular tachycardias. Am J Cardiol. 70:1992;1213-1215.
31. Wu D, Yeh S, Wang C, Wen M, Lin F. A simple technique for selective radiofrequency ablation of the slow pathway in atrioventricular node reentrant tachycardia. J Am Coll Cardiol. 21:1993;1612-1621.
32. Clair W, Wilkinson W, McCarthy E, Page R, Pritchett E. Spontaneous occurrence of paroxysmal atrial tachycardia and paroxysmal supraventricular tachycardia in untreated patients. Circulation. 87:1993;1112-1114.
33. Wu D, Denes P, Amat-y-Leon F, et al. Clinical, electrocardiographic and electrophysiologic observations in patients with paroxysmal supraventricular tachycardia. Am J Cardiol. 41:1978;1041-1051.
34. DiMarco J, Miles W, Akhtar M, et al. Adenosine for paroxysmal supraventricular tachycardia dose ranging and comparison with verapamil . Ann Intern Med. 113:1990;104-110.
35. Bhandari A, Anderson J, Gilbert M, et al. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation a transtelephonic monitoring study . Am Heart J. 124:1992;381-386.
36. den Dulk K, Brugada P, Smeets J, Wellens H. Long-term antitachycardia pacing experience for supraventricular tachycardia. PACE. 13:1990;1020-1030.
37. Giraudon G, Klein G, Sharma A, Yee R, Kaushik R, Fujimura O. Skeletonization of the atrioventricular node for AV node reentrant tachycardia experience with 32 patients . Ann Thorac Surg. 49:1990;565-573.
38. Sintetos A, Roark S, Smith M, McCarthy E, Lee K, Pritchett E. Incidence of symptomatic tachycardia in untreated patients with paroxysmal supraventricular tachycardia. Arch Intern Med. 146:1986;2205-2209.
39. Henthorn R, Waldo A, Anderson J, et al. Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. Circulation. 83:1991;119-125.
40. Dorian P, Naccarelli G, Coumel P, Hohnloser S, Maser M. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. Am J Cardiol. 77:(Suppl A):1996;89A-95A.
41. Hopson J, Buxton A, Rinkenberger R, et al. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias results of a multicenter trial . Am J Cardiol. 77:(Suppl A):1996;72A-82A.
42. Kugler J, Danford D, Deal B, et al. Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. N Engl J Med. 330:1994;1481-1487.
43. Bigger J, Goldreyer B. The mechanism of supraventricular tachycardia. Circulation. 42:1970;673-688.
44. Goldreyer B, Damato A. The essential role of atrioventricular conduction delay in the initiation of paroxysmal supraventricular tachycardia. Circulation. 43:1971;679-687.
45. Wellens H, Smeets J, Gorgels A, Farré J. The Wolff-Parkinson-White syndrome. Mandel W. Cardiac Arrhythmias Their Mechanisms, Diagnosis, and Management . 3rd ed. 1995;393-395 Lippincott, Philadelphia.
46. Kannel W. Clinical misconceptions dispelled by epidemiological research. Circulation. 92:1995;3350-3360.
47. Layde P, Broste S, Desbiens N, et al. Generalizability of clinical studies conducted at tertiary care medical centers a population-based analysis . J Clin Epidemiol. 49:1996;835-841.
48. Mannino M, Metha D, Gomes J. Current treatment options for paroxysmal supraventricular tachycardia. Am Heart J. 127:1994;475-480.
49. Scheinman M. Radiofrequency catheter ablation for patients with supraventricular tachycardia. PACE. 16:1993;671-679.
50. Smith P, Vidaillet H Jr, Hayes J, Schmeltzer J. Radiofrequency ablation in the Medicare population [abstract]. PACE. 20:1997;1213.
51. Rosano G, Leonardo F, Sarrel P, Beale C, De Luca F, Collins P. Cyclic variation in paroxysmal supraventricular tachycardia in women. Lancet. 347:1996;786-788.
52. Towbin J. New revelations about the long QT syndrome. N Engl J Med. 333:1995;384-385.